About this trial
Total hip arthroplasty (THA) causes moderate-to-severe postoperative pain. The PROSPECT guideline recommends the supra-inguinal fascia iliaca compartment block (SI-FICB) for THA, whereas evidence for newer quadratus-lumborum-family blocks is limited. The quadro-iliac plane block (QIPB) is a recently described fascial plane block, and no study has compared QIPB with SI-FICB head-to-head in any surgical context. In this prospective, double-blind, patients undergoing elective THA who receive one of the two routinely used preoperative blocks (SI-FICB or QIPB, chosen by the attending anesthesiologist as part of routine care) are systematically observed and compared. The primary objective is to assess whether the postoperative analgesic efficacy of QIPB is non-inferior to SI-FICB, using the resting NRS pain score at 6 hours postoperatively as the primary endpoint (non-inferiority margin Δ = 1.3).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18-75 years
Scheduled for elective primary total hip arthroplasty
ASA physical status I-III
Able to understand and communicate in Turkish and complete assessment scales
Disqualifiers
Known allergy/contraindication to any local anesthetic, including bupivacaine
Coagulopathy or anticoagulant/antiplatelet therapy contraindicating block (per ASRA 2022)
Active infection or skin breakdown at the block site
Chronic opioid use (≥3 months daily) or history of opioid dependence
Trial design
Parallel
Treatments tested in this trial
Supra-Inguinal Fascia Iliaca Compartment Block
Procedure/SurgerySIFICB is an ultrasound-guided fascial plane block performed via a supra-inguinal approach to the iliac fascia compartment, targeting the femoral nerve, lateral femoral cutaneous nerve, and obturator nerve. Single-shot, US-guided, 40 mL 0.25% bupivacaine, before GA induction.
Quadro-Iliac Plane Block
Procedure/SurgeryQIPB is a facial plane block performed under ultrasound guidance with local anesthetic in the interfascial plane between the erector spinae and the quadratus lumborum muscle, at the distal attachment site of the quadratus lumborum muscle on the iliac crest. Single-shot, US-guided, 40 mL 0.25% bupivacaine, before GA induction.
Treatment groups
Trial outcomes
Primary outcomes
Pain intensity at rest at 6 hours postoperatively
Numeric Rating Scale (NRS), 0 = no pain to 10 = worst imaginable pain, measured at rest by a blinded assessor. Non-inferiority margin Δ = 1.3 NRS points.
Secondary outcomes
NRS pain at rest
NRS pain on movement (active hip flexion)
Cumulative opioid consumption
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: